Know Your IPO: GoodRx, Digging Into Nike's Earnings & Anaplan CEO

The Dow closed down 525 points, swinging 680+ points, and Jim Cramer is helping investors navigate the ongoing bear market. Then, as the wave of public offerings continues, Cramer's taking a closer look at today's IPO GoodRx and how it might fit into your portfolio. Next, as the aftershocks of Nike's better-than-expected earnings continue to shake up the market, what should investors do with the stock as it hits all-time highs? Cramer's digging deeper into the call and where to go from here. Plus, Cramer's exclusive with Anaplan CEO Frank Calderoni. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.